Burmester, G. R., Panaccione, R., Gordon, K. B., McIlraith, M. J., & Lacerda, A. P. M. (2013). Adalimumab: Long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease. BMJ Group.

Burmester, Gerd R., Remo Panaccione, Kenneth B. Gordon, Melissa J. McIlraith, and Ana P M. Lacerda. Adalimumab: Long-term Safety in 23 458 Patients From Global Clinical Trials in Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Psoriasis and Crohn's Disease. BMJ Group, 2013.

Burmester, Gerd R., et al. Adalimumab: Long-term Safety in 23 458 Patients From Global Clinical Trials in Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Psoriasis and Crohn's Disease. BMJ Group, 2013.